⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Drishti Discoveries Ltd and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Drishti Discoveries Ltd
↗Cambridge, United Kingdom
Drishti Discoveries is a preclinical-stage biotechnology company based in Cambridge, UK. The company specializes in developing in-vivo gene therapies by leveraging a proprietary, patented artificial microRNA technology that enables sustained knockdown of target gene expression.
The company's primary focus is on addressing high-unmet-need conditions, particularly neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and rare inherited diseases. By converting cells into 'RNAi-producing factories,' Drishti aims to provide long-term therapeutic effects through a single course of treatment.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$0.5M
Investors:Start Codon, Innovate UK
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Gene therapy, RNAi, AAV
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Start Codon (Accelerator), Innovate UK (Grant funding)
COMPETITION
Position:Niche Player
Competitors:Jazz Pharmaceuticals, Sana Biotechnology, Ideaya Biosciences
LEADERSHIP
Key Executives:
Sapan Gandhi - Founder
Scientific Founders:Sapan Gandhi
LINKS
Website:drishtidiscoveries.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Drishti Discoveries Ltd. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.